ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
| Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
| Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
| Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
| Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
| Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |